Aptamer Screening Service for Protein Antibody Receptors

What is an Aptamer Screening Service?

It is a contract-based service where a specialized laboratory uses Systematic Evolution of Ligands by EXponential enrichment (SELEX) to discover single-stranded DNA or RNA molecules (aptamers) that bind with high affinity and specificity to your target molecule (e.g., a protein, an antibody’s constant region, or a cell-surface receptor).

Core Service Components

A full-service provider typically offers an end-to-end pipeline:

1. Project Design & Target Preparation

• Consultation: Defining the goal (e.g., detection, inhibition, delivery).

• Target Characterization: Ensuring the target (purified protein, antibody, receptor-expressing cells) is properly formatted and validated.

• Negative Selection/Counter-SELEX: Designing the screening to avoid binders to similar, non-target structures (e.g., the Fc region of a different antibody isotype, a common cell surface protein).

2. Library & Selection (The Core SELEX Process)

• Library Design: Using a diverse random oligonucleotide library (typically 10^14 – 10^15 unique sequences).

• Selection Method: The choice of method is critical and depends on the target:

  • Protein SELEX: For purified, soluble targets immobilized on beads or in solution.

  • Cell-SELEX: For membrane receptors in their native conformation on live cells. Excellent for discovering aptamers to unknown receptor complexes.

  • Capture-SELEX/Toggle-SELEX: For difficult-to-immobilize targets or to increase stringency.

  • In Vivo SELEX: For discovering aptamers that home to specific tissues in vivo.

• Iterative Rounds: Typically 8-15 rounds of binding, partitioning, and amplification to enrich high-affinity binders.

3. Sequencing & Bioinformatics

• Next-Generation Sequencing (NGS): Analyzing the enriched pool to identify candidate sequences and families.

• Bioinformatic Analysis: Clustering related sequences, identifying consensus motifs, and predicting secondary structures.

4. Candidate Validation & Characterization

• Synthesis: Chemically synthesizing the top candidate aptamers (often with modifications like 2′-F, 2′-O-Me for RNA stability).

• Binding Assays: Using techniques like Surface Plasmon Resonance (SPR), Bio-Layer Interferometry (BLI), or ELISA-like (ELASA) to measure affinity (Kd) and specificity.

• Functional Assays: Testing for desired activity (e.g., receptor antagonism/agonism, inhibition of protein-protein interaction).

Key Applications for Your Mentioned Targets

• Proteins: Enzymes, cytokines, biomarkers. Aptamers can be inhibitors, detection probes, or capture agents.

• Antibodies: Aptamers can bind to the Fc region for universal detection, or to the idiotype (variable region) for highly specific recognition of a single antibody clone.

• Receptors: Cell-surface targets (e.g., GPCRs, Receptor Tyrosine Kinases). Aptamers can act as antagonistic/agonistic drugs or targeting agents for drug delivery.

Critical Factors When Choosing a Service Provider

Leading Providers in the Field (Examples)

• Aptamer Group: Known for their SOMAmer (Slow Off-rate Modified Aptamer) technology, which uses an expanded genetic alphabet for protein-like diversity.

• Aptagen, LLC: Offers custom aptamer development and a catalog of “AptaBodies.”

• Base Pair Biotechnologies: Provides custom screening and has a focus on diagnostic and therapeutic applications.

• TriLink BioTechnologies (part of Maravai LifeSciences): Offers aptamer discovery services and also supplies critical modified nucleotides.

• Academic Core Facilities: Many universities have core labs (e.g., at UC Boulder, SomaLogic spin-offs) that offer collaborative or fee-for-service screening.

Decision Checklist Before Engaging

1. Define Success: What is the minimum affinity (Kd) and what cross-reactivities are unacceptable?

2. Prepare Your Target: High-purity, well-characterized target is essential. For Cell-SELEX, have a relevant negative cell line ready.

3. Budget for the Full Project: Include discovery, validation, and initial optimization phases.

4. Review IP Terms Meticulously: Engage your technology transfer office or legal counsel.

5. Ask for References: Speak to past clients with similar projects.

Strategic Advantages of Aptamers vs. Antibodies

• In vitro synthesis: No batch-to-batch variability, no animals required.

• Chemical stability: Tolerant of heat, pH, and denaturants (especially DNA aptamers).

• Reversible denaturation: Can be refolded repeatedly.

• Ease of modification: Can be chemically tagged with precision at defined sites.

• Small size: Better tissue penetration for imaging/therapeutics.

By clearly defining your project goals and carefully evaluating providers based on the criteria above, you can successfully leverage aptamer screening services to obtain powerful molecular tools for research, diagnostics, or therapeutic development.